Directory

>

Stephan Grupp

avatar

Stephan Grupp

Cellular Therapy and Transplant Section Chief | Children's Hospital of Philadelphia

United States

View contact details (it's free)

Stephan Grupp

Summary

Stephan Grupp is a leading expert in the field of pediatric hematology and oncology, specializing in sickle cell gene therapy and CAR T cell therapy. As the Director of the Cancer Immunotherapy and Cell Therapy/Transplant Section at the Children's Hospital of Philadelphia (CHOP) and a Professor at the University of Pennsylvania, he has made significant contributions to the advancement of cancer therapies for children. With a robust background in translational research, he leads multiple CAR T cell studies and global registration trials, including the FDA-approved CTL019 therapy. Stephan's work has not only transformed treatment protocols but also provided hope to countless families facing pediatric cancers. His dedication to research is complemented by his leadership in the national Children's Oncology Group. Recognized for his impactful contributions, he is a member of the National Academy of Medicine and has received various awards throughout his career. His passion for innovation continues to drive advancements in the treatment of high-risk pediatric cancers.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Stephan Grupp

Work Experience

company logo

Cellular Therapy and Transplant Section Chief at

Children's Hospital of Philadelphia

May 2017 - Present

company logo

Director of Cancer Immunotherapy Frontier Program at

The Childrens Hospital Of Philadelphia

July 2015 - Present

company logo

Professor at

Perelman School Of Medicine At The University Of Pennsylvania

February 1996 - Present

company logo

Director, Cell Therapy and Transplant at

Children's Hospital of Philadelphia

February 1996 - Present

company logo

Director of Translational Research at

The Childrens Hospital Of Philadelphia

February 2005 - February 2018

company logo

Instructor in Pediatrics at

Harvard Medical School

January 1992 - January 1995

company logo

Hematology/Oncology Fellow at

Dana-Farber Cancer Institute

January 1989 - January 1992

company logo

Intern and resident at

Boston Children's Hospital

January 1987 - January 1989

Logos provided by Logo.dev

Stephan Grupp

Education

University of Cincinnati College of Medicine, Doctor Of Medicine (M.D.)

January 1981 - January 1987

University of Cincinnati College of Medicine, Doctor Of Philosophy (Ph.D.)

January 1981 - January 1985

University of Cincinnati, Bachelor's Degree

January 1977 - January 1981

Frequently Asked Questions about Stephan Grupp

What is Stephan Grupp email address?

Stephan Grupp's primary email address is ******@chop.edu. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Stephan Grupp work for?

Stephan Grupp is a Cellular Therapy and Transplant Section Chief at Children's Hospital of Philadelphia, a company specializing in Management services.

Where Stephan Grupp graduated from?

Stephan Grupp holds a degree in Medicine from University of Cincinnati College of Medicine.

How can I directly contact Stephan Grupp?

To contact Stephan Grupp directly, you can use the email address ******@chop.edu. Complete contact information is available upon registration with Muraena.

Who is Stephan Grupp?

Stephan Grupp is a leading expert in the field of pediatric hematology and oncology, specializing in sickle cell gene therapy and CAR T cell therapy. As the Director of the Cancer Immunotherapy and Cell Therapy/Transplant Section at the Children's Hospital of Philadelphia (CHOP) and a Professor at the University of Pennsylvania, he has made significant contributions to the advancement of cancer therapies for children. With a robust background in translational research, he leads multiple CAR T cell studies and global registration trials, including the FDA-approved CTL019 therapy. Stephan's work has not only transformed treatment protocols but also provided hope to countless families facing pediatric cancers. His dedication to research is complemented by his leadership in the national Children's Oncology Group. Recognized for his impactful contributions, he is a member of the National Academy of Medicine and has received various awards throughout his career. His passion for innovation continues to drive advancements in the treatment of high-risk pediatric cancers.

Stephan`s contact details

mail

******@chop.edu

*****@email.chop.edu

******@upenn.edu

Colleagues

avatar
Evan Fieldston

VP & Associate Chief Medical Officer, Philadelphia Campus

avatar
Andrew Duong

Research Assistant

avatar
Gilbert Davis

Vice President, Chief Diversity Officer

avatar
Mbi Bimal Desai Md Famia Faap

Associate Professor of Clinical Pediatrics

avatar
Donald Moore

Senior Vice President - Real Estate, Facilities & Operations

avatar
Earnest James Paul Daniel

American College of Medical Genetics (ACMG) - Trainee Fellow (board-eligible)

Elizabeth Younkins

Avp Care Network

Richard Aplenc

Chief Clinical Research Officer

Jamie Hoffman

COO, Neonatology

View Contact details (it's free)
Request Profile Removal